CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-17 | Vasista Vittal Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −30,000 | 204,900 | ||
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −1,515 | $70.46 | $107K | 339,505 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −100 | $71.10 | $7K | 339,405 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −624 | $73.04 | $46K | 338,781 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −1,399 | $73.80 | $103K | 337,382 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −622 | $75.29 | $47K | 336,760 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −1,450 | $76.72 | $111K | 335,310 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −900 | $77.88 | $70K | 334,410 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −400 | $78.73 | $31K | 334,010 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −200 | $79.45 | $16K | 333,810 |
| 2018-09-17 | Mills Kenneth T. President and CEO | Sale | −300 | $81.12 | $24K | 333,510 |
| 2018-08-27 | Mills Kenneth T. President and CEO | Exercise or conversion | +145,000 | $0.85 | $123K | 348,530 |
| 2018-08-27 | Mills Kenneth T. President and CEO | Sale | −5,757 | $66.29 | $382K | 342,773 |
| 2018-08-27 | Mills Kenneth T. President and CEO | Sale | −1,753 | $67.02 | $117K | 341,020 |
| 2018-08-27 | Mills Kenneth T. President and CEO | Exercise or conversion · Employee Stock Option (Right to Buy) | −145,000 | 234,670 | ||
| 2018-08-20 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion | +5,000 | $12.10 | $61K | 22,669 |
| 2018-08-20 | Christmas Patrick J. SVP, General Counsel | Sale | −3,400 | $65.75 | $224K | 19,269 |
| 2018-08-20 | Christmas Patrick J. SVP, General Counsel | Sale | −1,600 | $66.41 | $106K | 17,669 |
| 2018-08-20 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion · Employee Stock Option (Right to Buy) | −5,000 | 63,472 | ||
| 2018-08-15 | Vasista Vittal Chief Financial Officer | Sale | −6,199 | $65.31 | $405K | 123,584 |
Page 39 of 43 · 852 trades